Windtree Therapeutics announces reduction of Preferred Series C, D shares

Windtree Therapeutics (WINT) announced large reductions in outstanding shares of its preferred series C and D shares. Only 19 preferred series C shares remain. The majority of the Company’s Series C Convertible Preferred Stock and Series D Convertible Preferred Stock has been converted or redeemed. 19 shares of Series C Preferred Stock and 1,161 shares of Series D Preferred Stock remain outstanding as of July 25, 2025, representing a 99.3% reduction in the Series C Preferred Stock and a 68.5% reduction in the Series D Preferred Stock between April 15, 2025 and July 25, 2025. The Company previously announced its plan to launch a BNB crypto treasury strategy with an agreement for $60 million investment led by Build and Build Corp. With Up To $140 Million More In Follow On Subscriptions. Since the announcement, the price of BNB coin has appreciated over 17%. The Company also announced further investment in the treasury strategy of up to $700 million committed to BNB acquisitions, reinforcing its innovative crypto treasury strategy. The agreement and investment are subject to stockholder approval.